Co-administration of the mTORC1/TORC2 inhibitor INK128 and the Bcl-2/Bcl-xL antagonist ABT-737 kills human myeloid leukemia cells through Mcl-1 down-regulation and AKT inactivation

Effects of concurrent inhibition of mTORC1/2 and Bcl-2/Bcl-xL in human acute myeloid leukemia cells were examined. Tetracycline-inducible Bcl-2/Bcl-xL dual knockdown markedly sensitized acute myeloid leukemia cells to the dual TORC1/2 inhibitor INK128 in vitro as well as in vivo. Moreover, INK128 co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Rahmani, Mohamed, Aust, Mandy Mayo, Hawkins, Elisa, Parker, Rebecca E., Ross, Masey, Kmieciak, Maciej, Reshko, Leonid Borisovich, Rizzo, Kathryn A., Dumur, Catherine I., Ferreira-Gonzalez, Andrea, Grant, Steven
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4666331/
https://ncbi.nlm.nih.gov/pubmed/26452980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.130351
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados